298 CO-MORBIDITIES DO NOT AFFECT THE PROGRESSION OF RADIOGRAPHIC OA  by Dieppe, P. et al.
Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256 S133
Abstract 297 – Table 1. Normative Values for Functional Tests
Timed up And Go (seconds) Stair Climbing Time (seconds) Six Minute Walk Test (meters)
Mean (SD) Range N Mean (SD) Range N Mean (SD) Range N
Healthy 6.76 (1.43) 4.24-10.97 63 9.53 (2.47) 5.88-17.83 63 2177 (392) 1418-3406 63
Moderate OA 8.65 (2.34) 4.36-17.64 144 15.50 (8.19) 4.63-55.00 143 1676 (395) 540-2596 144
End-Stage OA 9.98 (2.73) 3.10-21.67 181 19.79 (9.32) 6.25-55.73 181 1500 (395) 516-2565 158
1 Month after TKA 12.07 (3.71) 6.35-29.85 249 27.39 (12.42) 7.88-86.28 249 1302 (333) 416-2278 189
6 Months after TKA 7.91 (1.84) 4.44-14.26 268 13.06 (5.27) 6.43-49.83 255 1782 (365) 516-2872 214
12 Months after TKA 7.80 (1.78) 4.13-14.44 270 12.48 (4.32) 4.76-29.69 262 1821 (359) 890-2916 219
24 Months after TKA 7.93 (2.31) 4.43-23.28 169 12.40 (4.28) 6.12-29.33 166 1775 (373) 274-2680 136
Abstract 297 – Table 2. Normative Values for Self-Reported Function
Knee Outcome Survey - Activities of SF-36 Physical Component Score Global Rating Score
Daily Living Subscale
Mean (SD) Range N Mean (SD) Range N Mean (SD) Range N
Healthy 98.0 (3.8) 85.7-100.0 44 54.0 (5.0) 37.1 60.3 59 99 (2) 88-100 63
Moderate OA 60.2 (21.2) 14.5-95.7 146 35.5 (9.7) 18.1 55.5 130 61 (25) 0-99 144
End-Stage OA 51.1 (17.1) 8.6-92.9 176 32.1 (8.3) 15.6 56.6 182 56 (21) 10-100 182
1 Month after TKA 56.0 (13.3) 4.3-88.6 241 29.5 (6.6) 16.6 50.7 248 55 (19) 10-100 248
6 Months after TKA 84.6 (10.8) 47.1-100.0 264 47.1 (8.1) 22.4 64.4 254 88 (13) 25-100 253
12 Months after TKA 85.6 (11.1) 40.0-100.0 261 47.3 (8.3) 15.6 62.8 259 91 (10) 25-100 261
24 Months after TKA 84.9 (12.8) 30.0-100.0 172 46.4 (9.4) 13.6 61.0 171 90 (12) 20-100 172
Abstract 297 – Table 3. Normative Values for Clinical Measures
Isometric Quadriceps Strength of Active Knee Flexion Range of Motion Active Knee Extension Range ofMotion
the Involved Limb (N/BMI) (degrees) (degrees)
Mean (SD) Range N Mean (SD) Range N Mean (SD) Range N
Healthy 28.95 (9.26) 5.86-55.03 62 139 (7) 123-154 64 -1 (3) -10-7 63
Moderate OA 23.18 (10.92) 4.77-64.44 139 127 (11) 93-150 148 1 (4) -10-14 149
End-Stage OA 19.33 (7.71) 3.40-40.04 181 119 (13) 64-146 179 4 (5) -8-25 181
1 Month after TKA 10.76 (5.02) 1.17-31.44 247 100 (16) 50-138 245 6 (4) -3-25 246
6 Months after TKA 19.07 (7.75) 3.68-41.65 265 119 (10) 79-145 264 1 (5) -8-56 265
12 Months after TKA 20.35 (8.33) 4.09-45.53 266 121 (10) 80-148 264 0 (3) -7-10 266
24 Months after TKA 20.12 (8.92) 3.30-49.10 159 121 (11) 75-144 170 0 (3) -11-9 170
TKA, the average scores on KOS-ADLS increased and scores on the GRS
remained fairly constant, while there was a considerable decrease in the
functional performance measures. There was an increase in self-perceived
and objective functional performance between 1 and 6 months after TKA,
however scores tended to plateau after this time. Using the data from
persons with moderate OA, age, knee extension range of motion and scores
on the KOS-ADLS were predictive of undergoing TKA in 2 years (R2 = 0.403,
p<0.001). Younger subjects with greater KOS-ADLS scores and no knee
ﬂexion contracture were less likely to undergo TKA in 2 years. Negative
scores for active knee extension indicate hyperextension on Table 3.
Conclusions: Accurate assessment of disability associated with OA and the
functional recovery after TKA requires the use of physical performance
tests, self-report questionnaires and clinical measurements. There is a
disparity between self-perceived ability and actual functional capabilities,
and this disparity is particularly apparent in the early post-operative stage.
The Delaware Osteoarthritis Proﬁle provides a comprehensive evaluation
of disability and recovery and the normative values can be used by clin-
icians to evaluate individual patient progress. The test can be completed
within the 45-60 minute time frame typically allotted for physical therapy
evaluations and re-evaluations.
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Purpose: Radiographic features characteristic of osteoarthritis (OA) are
strongly age related. Older people with OA commonly have co-morbidities.
It has been suggested that these co-morbidities, particularly obesity and
cardiovascular problems, might have an inﬂuence on the progression of
radiographic changes.
To explore this hypothesis we have examined the associations between the
progression of structural changes in joints over 8 years with baseline data
on co-morbidities in a large community based cohort.
Methods: In 1994 and 1995, 2703 subjects reporting hip and/or knee pain
in the Somerset and Avon Survey of Health (SASH), a community-based
prospect cohort study, completed health questionnaires, underwent clinical
examination and knee radiographs. 8 years later, the cohort was contacted
again, and those who were willing and available had a repeat examination
and further radiographs taken. Radiography were examined blind to identi-
ﬁcation and examination order by a single assessor who recorded Kellgren
and Lawrence (K&L) grades. Paired knee radiographs were available in 658
subjects. 434 subjects had radiographic signs of OA as deﬁned by a K&L
grade of 1 or more at baseline. Then, we distinguished between progressors,
in whom the K&L score had increased over 8 years, and non-progressors
with the same or lower grades at 8 years. We grouped self-reported
types of co-morbidity, including arterial hypertension, and cardiovascular
conditions (myocardial infarction, angina, stroke or intermittent claudica-
tion). Then, we used multivariable logistic regression analyses to determine
whether different types of co-morbidity were associated with progression,
also adjusting for age and gender.
Results: Radiographic progression occurred in 213 of the 434 subjects
(49%), and in 44 subjects (10%) the K&L score increased by two or more
grades. Co-morbidities were common, particularly arterial hypertension
(87, 20%), cardiovascular conditions (76, 18%), chronic obstructive pul-
monary disease (61, 14%) and conditions of the eye (23, 4%). The Table
shows adjusted odds ratios for the association of different types of co-
morbidity with OA progression from multivariable analysis. There was
Table 1. Odds ratio of OA progression adjusted for age and gender
Self-reported Co-morbidity Odds Ratio (95% CI)
COPD 1.09 (0.59-2.01)
Diabetes 2.94 (0.74-11.6)
Depression 0.74 (0.30-1.82)
Obesity 1.33 (0.81-2.18)
Arterial Hypertension 0.78 (0.45-1.36)
Cancer 2.84 (0.72-11.3)
Chronic inﬂammatory disease 1.10 (0.68-1.77)
Eye disease 0.65 (0.28-1.52)
Cardiovascular disease 0.96 (0.55-1.67)
S134 Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256
little evidence to suggest that any of the co-morbidities was associated
with progression, even though conﬁdence intervals were wide and did not
exclude clinically relevant associations.
Conclusions: These data do not support the hypothesis that the progression
of structural changes
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Purpose: To develop a method to characterize the thickness and microar-
chitecture of the subchondral bone plate (SBPlate) in health and disease.
Since the microarchitecture of the SBPlate is arranged in a depth-wise
gradient to distribute mechanical forces, methods for detecting perturba-
tions in this highly organized structure are needed. Interventions such as
marrow stimulation for cartilage repair are designed to create continuities
between the articular surface and the marrow cavity, but 40% of patients
do not respond. Abnormalities in the osteoarthritic SBPlate may explain
this.
Materials and Methods: Human medial and lateral femoral condyles from
donors (n=4) aged 21-46 years were scored for OA using the Outerbridge
grading system (0-5) and microCT scanned at 45 micron resolution with a
calibration phantom (GE Locus Explore). Bone mineral density (BMD) and
bone volume fraction (BVF) were calculated in traditional 3×3×10 mm3
regions of interest (ROIs) starting at the tidemark using Microview (ver 2.2
ABA). For depth-wise analyses additional 1×1×10 mm ROIs were created
around a central vertical axis. Voxel values at each horizontal plane along
the axis were condensed and tabulated as voxel density by depth (mm).
Workﬂows were created in Python (ver 3.1.1) and R (www.r-project.org) to
calculate BMD, and BVF. A 2 cm2 chondral defect was created on the same
specimens, a 30o microcfracture awl (Linvatec, Florida) was used to make
four 3 mm deep holes. Following microfracture the specimens underwent
microCT imaging again. Additional software was created to determine the
BMD and BVF in the horizontal plane and the data tabulated as BMD or
BVF by radial distance (mm) from the central axis at 0.5 mm intervals.
Histological sections of the condyles were cut and stained, then correlated
with microCT images.
Results: The human SBPlate in the normal femoral condyle consists of
a horizontal condensation of one or two trabeculae 0.5 mm thick that
is supported by frequent vertical trabeculae. In early OA sclerosis was
represented by multiple horizontal trabeculae in a laminar arrangement
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comprising a signiﬁcantly thicker (2-4mm) SBPlate (Fig. 1a). Mean BMD
and BVF from standard ROIs were insensitive to subtle changes in OA
but depth-wise analysis plots showed sustained peaks representing a
thicker, more mineralized SBplate (Patient 1 - Figs. 2 & 3). Microfacture
holes in normal bone penetrated the thin SBPlate and crushed or dis-
placed deeper vertical trabeculae creating communication with the deeper
marrow spaces. Microfracture holes in sclerotic OA bone were lined with
compacted trabecular bone that ﬁlled the marrow spaces (Fig. 1b). Operator
dependent compaction of bone was present in the superior quadrant of the
microfracture hole.
Figure 4
Conclusion: Depth-wise analysis of bone morphometric parameters is a
sensitive tool to evaluate changes in the SBPlate as joint disease progresses.
Microfracture may fail to create marrow-articular surface communications
for inﬂux of repair tissue as sclerotic bone accumulates. Bone compaction
is exacerbated when the operator drives the awl along the joint surface,
as if "plowing" a furrow. The surgeon is faced with a dilemma whether
to debride the sclerotic SBPlate and risk articular surface collapse or
subchondral cyst formation. Modiﬁcation of the microfracture procedure in
patients with sclerotic bone may be warranted.
